A detailed history of Asset Dedication, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 51 shares of TXG stock, worth $1,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Holding current value
$1,139
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$19.45 - $37.37 $991 - $1,905
51 New
51 $0
Q2 2022

Jul 19, 2022

SELL
$36.95 - $82.41 $997 - $2,225
-27 Closed
0 $0
Q3 2021

Oct 18, 2021

BUY
$145.58 - $192.14 $3,930 - $5,187
27 New
27 $4,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.12B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.